Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Metagenomi (MGX) Invested Capital (2023 - 2025)

Metagenomi (MGX) has disclosed Invested Capital for 3 consecutive years, with $158.6 million as the latest value for Q4 2025.

  • Quarterly Invested Capital fell 32.47% to $158.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $158.6 million through Dec 2025, down 32.47% year-over-year, with the annual reading at $158.6 million for FY2025, 32.47% down from the prior year.
  • Invested Capital for Q4 2025 was $158.6 million at Metagenomi, down from $178.4 million in the prior quarter.
  • The five-year high for Invested Capital was $275.6 million in Q1 2024, with the low at -$135.6 million in Q4 2023.
  • Average Invested Capital over 3 years is $121.1 million, with a median of $187.1 million recorded in 2025.
  • The sharpest move saw Invested Capital soared 214997.37% in 2024, then crashed 32.47% in 2025.
  • Over 3 years, Invested Capital stood at -$135.6 million in 2023, then soared by 273.22% to $234.9 million in 2024, then plummeted by 32.47% to $158.6 million in 2025.
  • According to Business Quant data, Invested Capital over the past three periods came in at $158.6 million, $178.4 million, and $195.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.